| Title |
Vaccines for preventing pneumococcal infection in adults
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2013
|
| DOI | 10.1002/14651858.cd000422.pub3 |
| Pubmed ID | |
| Authors |
Sarah Moberley, John Holden, David Paul Tatham, Ross M Andrews |
| Abstract |
Diseases caused by Streptococcus pneumoniae (S. pneumoniae) continue to cause substantial morbidity and mortality globally. Whilst pneumococcal polysaccharide vaccines (PPVs) have the potential to prevent disease and death, the degree of protection afforded against various clinical endpoints and within different populations is uncertain. |
Twitter Demographics
The data shown below were collected from the profiles of 26 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 23% |
| United Kingdom | 2 | 8% |
| Mexico | 1 | 4% |
| Finland | 1 | 4% |
| Australia | 1 | 4% |
| Canada | 1 | 4% |
| Japan | 1 | 4% |
| Netherlands | 1 | 4% |
| Unknown | 12 | 46% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 23 | 88% |
| Scientists | 2 | 8% |
| Practitioners (doctors, other healthcare professionals) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 459 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 4 | <1% |
| United Kingdom | 4 | <1% |
| Germany | 2 | <1% |
| Switzerland | 1 | <1% |
| Brazil | 1 | <1% |
| Canada | 1 | <1% |
| Kenya | 1 | <1% |
| Denmark | 1 | <1% |
| Taiwan | 1 | <1% |
| Other | 2 | <1% |
| Unknown | 441 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 71 | 15% |
| Student > Master | 56 | 12% |
| Student > Bachelor | 55 | 12% |
| Student > Ph. D. Student | 38 | 8% |
| Other | 35 | 8% |
| Other | 100 | 22% |
| Unknown | 104 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 188 | 41% |
| Nursing and Health Professions | 27 | 6% |
| Agricultural and Biological Sciences | 27 | 6% |
| Immunology and Microbiology | 18 | 4% |
| Biochemistry, Genetics and Molecular Biology | 14 | 3% |
| Other | 73 | 16% |
| Unknown | 112 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 50. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 June 2023.
All research outputs
#802,299
of 24,495,755 outputs
Outputs from Cochrane database of systematic reviews
#1,601
of 12,927 outputs
Outputs of similar age
#6,678
of 291,449 outputs
Outputs of similar age from Cochrane database of systematic reviews
#15
of 172 outputs
Altmetric has tracked 24,495,755 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,927 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.7. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 291,449 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 172 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.